Deflux钙化导致迟发性梗阻及肾功能丧失:一例病例报告
本文报告一名11岁女孩在接受Deflux(右旋糖酐/透明质酸共聚物)治疗膀胱输尿管反流近8年后,出现无症状的严重同侧输尿管肾积水,并伴有肾功能丧失,无明确危险因素。该病例提示Deflux迟发并发症包括钙化和迟发性输尿管梗阻。
要点
- Deflux治疗膀胱输尿管反流早期并发症约1%。
- 迟发并发症包括钙化和迟发性输尿管梗阻,认识不足。
- 无症状严重同侧输尿管肾积水可在Deflux治疗后近8年出现。
核心结论
- Deflux使用后近8年可发生无症状严重同侧输尿管肾积水并伴肾功能丧失,患者无明确危险因素。
研究设计与样本
- 病例报告:一名11岁女孩,既往因膀胱输尿管反流接受Deflux治疗。
主要发现
- 患者在Deflux治疗后近8年发现无症状的严重同侧输尿管肾积水。
- 该病例为Deflux使用后无明确危险因素患者出现肾功能丧失的罕见实例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dextranomer/hyaluronic acid (Deflux) has been widely used in the treatment of vesicoureteral reflux in the pediatric population. It has demonstrated acceptable early efficacy with minimal morbidity. Early complications from Deflux have been reported to occur in approximately 1% of cases. However, late complications from Deflux use, including calcification and delayed ureteral obstruction, are less well understood. We present the case of an asymptomatic 11 year old girl with severe ipsilateral hydroureteronephrosis, identified nearly 8 years after treatment. This case details a rare instance of loss of renal function after Deflux use in a patient with no apparent risk factors.
引用
- Pham H, Au J, Jones E, et al. Deflux Calcification Leading to Delayed Obstruction and Loss of Renal Function: A Case Report. Urology. 2022. PMID: 35537561. doi:10.1016/j.urology.2022.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。